Skip to main content

Table 1 Patients’ characteristics

From: Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

 

Average Hb < 10.1

10.1 ≤ Average Hb < 11.0

11.0 ≤ Average Hb

 

Baseline

At dialysis

Endpoint

Baseline

At dialysis

Endpoint

Baseline

At dialysis

Endpoint

N

5

  

6

  

6

  

Term before dialysis (days)

340.8 ± 32.8

  

283.7 ± 132.0

  

251.7 ± 221.4

  

Age (years old)

71.8 ± 10.7

  

62.7 ± 11.2

  

56.3 ± 13.4

  

Sex (n, (% men))

5, (100.0)

  

4, (66.7)

  

4, (66.7)

  

Diabetes (n, %)

4, (80.0)

  

4, (66.7)

  

5, (83.3)

  

Weight (kg)

59.2 ± 13.4

60.4 ± 14.4

58.0 ± 11.5

68.8 ± 10.4

69.0 ± 10.8

67.0 ± 10.8

64.5 ± 18.2

65.2 ± 17.3

61.0 ± 12.5

SBP (mmHg)

138.0 ± 14.0

141.2 ± 19.7

137.6 ± 17.8

143.0 ± 13.5

143.0 ± 11.5

142.0 ± 10.1

134.0 ± 9.9

128.7 ± 17.4

139.2 ± 11.1

DBP (mmHg)

76.5 ± 5.7

75.6 ± 12.7

73.2 ± 20.0

73.5 ± 14.3

72.7 ± 11.0

72.0 ± 15.9

82.5 ± 14.5

70.3 ± 9.9

85.2 ± 4.1

Hemoglobin (g/dL)

9.6 ± 0.8

9.7 ± 0.7

10.1 ± 0.8

9.5 ± 1.4

9.9 ± 0.7

10.9 ± 0.5#

9.9 ± 0.8

10.9 ± 0.8*

12.2 ± 0.8*, **, #

ERI

42.0 ± 32.6

37.1 ± 16.8

33.1 ± 5.2

32.7 ± 21.8

26.8 ± 14.7

29.8 ± 19.4

36.1 ± 20.1

37.4 ± 20.7

23.6 ± 20.8##

TSAT (%)

34.5 [30.1, 45.0]

23.7 [19.4, 43.7]

20.4 [16.9, 21.2]

32.8 [29.7, 36.2]

17.2 [11.6, 38.5]

31.6 [24.8, 45.0]*

32.8 [23.3, 44.4]

17.1 [12.6, 23.1]#

29.6 [22.2, 62.7]

Ferritin (mg/dL)

290 [121, 507]

176 [69, 256]

231 [69, 265]

139 [107, 341]

193 [62, 537]

247 [125, 361]

140 [103, 271]

122 [68, 310]

172 [97, 442]

BNP (pg/mL)

74 [32, 163]

482 [106, 1130]

648 [67, 1189]

138 [62, 177]

47 [18, 409]

269 [153, 343]

26 [19, 34]

41 [21, 88]

50 [19, 191]

Intact PTH (mg/dL)

219 [161, 700]

215 [115, 548]

320 [156, 648]

406 [139, 817]

237 [15, 673]

141 [93, 282]

287 [283, 722]

220 [65, 485]

161 [93, 320]

Correction Ca (mg/dL)

8.7 ± 0.2

9.1 ± 0.9

9.3 ± 0.7#

8.8 ± 0.4

8.7 ± 0.3

8.6 ± 0.2

8.6 ± 0.5

9.4 ± 0.9

9.5 ± 0.8

Phosphorus (mg/dL)

4.2 ± 1.3

5.1 ± 1.3

5.7 ± 1.1#

4.4 ± 0.5

5.0 ± 1.2

5.0 ± 1.5

5.7 ± 0.5**

6.0 ± 1.2

5.7 ± 1.7

Albumin (mg/dL)

3.8 ± 0.4

3.3 ± 0.5

2.9 ± 0.7#

4.0 ± 0.5

3.6 ± 0.4

3.6 ± 0.5

4.0 ± 0.4

3.7 ± 0.4

3.5 ± 0.4

hsCRP (mg/dL)

0.07 [0.03, 0.10]

0.03 [0.01, 0.36]

0.03 [0.01, 0.14]

0.28 [0.15, 0.40]

0.14 [0.09, 0.80]

0.05 [0.03, 0.06]

0.09 [0.08, 0.10]

0.11 [0.06, 5.95]

0.16 [0.06, 0.30]

Creatinine (mg/dL)

4.7 ± 1.7

9.3 ± 3.4#

-

5.7 ± 2.1

8.7 ± 1.9#

-

7.0 ± 0.9*

10.3 ± 1.9#

-

Urinary protein (g/g Cr)

2.3 ± 1.0

3.9 ± 4.5

-

2.6 ± 1.9

1.9 ± 0.6

-

1.4 ± 1.1

1.5 ± 0.7

-

Echocardiography

 LVDd (mm)

52.0 ± 0.1

51.7 ± 3.4

55.7 ± 7.5

49.4 ± 7.2

48.9 ± 4.8

47.7 ± 3.8

49.8 ± 1.1

44.6 ± 4.9*

46.1 ± 4.3*

 Ejection fraction (%)

0.61 ± 0.19

0.60 ± 0.12

0.58 ± 0.10

0.70 ± 0.15

0.67 ± 0.13

0.67 ± 0.11

0.67 ± 0.01

0.71 ± 0.06

0.64 ± 0.09##

LVMI (g/m2)

163.5 ± 39.6

162.7 ± 45.7

205.9 ± 41.5

143.3 ± 45.3

143.1 ± 32.8

149.7 ± 25.8*

117.6 ± 17.7*

110.5 ± 31.1

123.2 ± 29.7*

 RWT

0.41 ± 0.02

0.48 ± 0.06

0.44 ± 0.06

0.45 ± 0.07

0.48 ± 0.04

0.50 ± 0.06

0.43 ± 0.04

0.49 ± 0.05#

0.48 ± 0.07

Treatment (n, (%))

 ARB

2, (40.0)

1, (20.0)

1, (20.0)

1, (16.7)

1, (16.7)

2, (33.3)

2, (33.3)

3, (50.0)

3, (50.0)

 CCB

1, (20.0)

1, (20.0)

1, (20.0)

0, (0.0)

0, (0.0)

1, (16.7)

3, (50.0)

3, (50.0)

4, (66.7)

 β-blocker

4, (80.0)

4, (80.0)

3, (60.0)

4, (66.7)

3, (50.0)

2, (33.3)

5, (83.3)

5, (83.3)

5, (83.3)

  1. Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, ERI Erythropoietin resistance index, TSAT Transferrin saturation, BNP brain natriuretic peptide, PTH Parathyroid hormone, Ca Calcium, hsCRP High-sensitivity C-reactive protein, LVDd Left ventricular diastolic dysfunction, LVMI Left ventricular mass index, RWT Relative wall thickness. Average Hb: average at baseline and dialysis
  2. * p < 0.05 vs. Average Hb < 10.1, **p < 0.05 vs. 10.1 ≤ Average Hb < 11.0 (unpaired test: Fisher’s exact test [nominal scale], t-test [continuous scale and parametric], Mann–Whitney U test [continuous scale and non-parametric])
  3. # p < 0.05 vs. Baseline, ##p < 0.05 vs. At dialysis (paired test: paired t-test [continuous scale and parametric], Wilcoxson signed-rank test [continuous scale and non-parametric])